Neuropsychiatric Disorders: Genetics and Targeted Therapy

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".

Deadline for manuscript submissions: 15 August 2025 | Viewed by 1062

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Brain and Cognitive Sciences, McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
2. Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Interests: synaptic plasticity; synaptic physiology; cognition; antidepressants; depression

E-Mail Website
Assistant Guest Editor
Department of Brain and Cognitive Sciences, McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Interests: synaptic physiology; neural circuits; interneurons; motivation

Special Issue Information

Dear Colleagues,

Neuropsychiatric disorders are a set of highly debilitating medical conditions that are etiologically complex and difficult to treat. Half of the global population will suffer from a neuropsychiatric condition at some point in their lifetime, making novel therapeutic development an exigent clinical priority. However, rational therapeutic design critically depends on scientific discoveries that provide actionable biological insights into the pathophysiology of disease. This requires an improved understanding of how gene × environment interactions confer neural circuit dysfunction, which is a unifying characteristic that all neuropsychiatric conditions share. Currently, additional evidence is needed to establish the following: (1) the functional impact of disease-related gene mutations on the proteins they encode; (2) how this contributes mechanistically to aberrant changes in the efficacy of synaptic transmission and plasticity; (3) whether this promotes clinically significant deviations in cognition, perception, emotion, and behavior; and (4) the role of environmental factors in potentiating (or mitigating) disease risk.

Our goal is to publish a multidisciplinary set of studies that reveal physiological processes through which genetic and/or environmental factors confer increased risk for neuropsychiatric conditions. This may include patient-derived genetic variants or site-specific mutations that are designed to test specific mechanistic hypotheses of cellular function. We also welcome submissions from subject areas including, but not limited to, the following: molecular mechanisms of synapse development and circuit assembly; transcriptional and epigenetic signatures of disease risk and/or therapeutic response; cell-type-specific neural circuit function in mood-related behavior; convergent pathways underlying neuropsychiatric comorbidities; notable preclinical model developments that broadly facilitate the study of neuropsychiatric phenotypes.

Contributions in the form of research articles, reviews, and commentaries are welcome.

Dr. Lace Riggs
Guest Editor

Dr. Xin Fu
Assistant Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuropsychiatric disorders
  • polygenetic interactions
  • genotype–phenotype correlations
  • neural circuits
  • synaptic transmission
  • synaptic plasticity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 701 KiB  
Review
Exploring the Potential of Precision Medicine in Neuropsychiatry: A Commentary on New Insights for Tailored Treatments Based on Genetic, Environmental, and Lifestyle Factors
by Jelena Milic, Milica Vucurovic, Dragana Jovic, Veroslava Stankovic, Edita Grego, Srdja Jankovic and Rosa Sapic
Genes 2025, 16(4), 371; https://doi.org/10.3390/genes16040371 - 24 Mar 2025
Viewed by 495
Abstract
Neuropsychiatric disorders are complex conditions with multifactorial etiologies, in which genetics play a pivotal role. Despite significant advancements in psychiatric research, traditional treatment options remain largely symptomatic, focusing on clinical signs without fully addressing the underlying biological causes. However, recent developments in precision [...] Read more.
Neuropsychiatric disorders are complex conditions with multifactorial etiologies, in which genetics play a pivotal role. Despite significant advancements in psychiatric research, traditional treatment options remain largely symptomatic, focusing on clinical signs without fully addressing the underlying biological causes. However, recent developments in precision medicine—an approach that tailors treatments based on genetic, environmental, and lifestyle factors—hold great promise for transforming the treatment of these disorders. By identifying specific genetic markers and understanding gene–environment interactions, precision medicine can offer more personalized and effective treatments, leading to better patient outcomes. Our primary aim was to explore how integrating genetic data with environmental factors could enhance the understanding and treatment of neuropsychiatric conditions such as schizophrenia, bipolar disorder, and depression. The secondary aim was to examine the potential of pharmacogenomics and gene therapy in improving therapeutic strategies. The results indicate that while significant progress has been made, challenges remain, including the complexity of genetic interactions and the need for more granular phenotypic data. In conclusion, precision medicine has the potential to revolutionize neuropsychiatric treatment by providing individualized care that considers genetic makeup, environmental influences, and lifestyle factors, paving the way for more effective therapies and improved patient outcomes. Full article
(This article belongs to the Special Issue Neuropsychiatric Disorders: Genetics and Targeted Therapy)
Show Figures

Figure A1

Back to TopTop